COVID-19: Page 2

  • Image attribution tooltip
    Getty Images

    Google launches new search tool for provider appointments, seeks FDA approval for Fitbit feature

    The tech giant is working to prop up its healthcare efforts following internal project shakiness that led the company to dismantle its Google Health business last year.

    By Rebecca Pifer • March 28, 2022
  • Image attribution tooltip


    Abbott awarded $1B US Army contract for COVID-19 antigen tests

    The award to Abbott Rapid Dx North America, for an undisclosed quantity of BinaxNOW tests, follows a $306 million contract in January as part of the Biden administration's efforts to purchase 1 billion at-home test kits. 

    By March 25, 2022
  • Image attribution tooltip
    Rebecca Pifer/MedTech Dive
    Deep Dive

    The case for hybrid care models

    Telehealth is increasingly being woven into healthcare organizations' future plans, giving hope to proponents of hybrid care models.

    By Rebecca Pifer • March 22, 2022
  • Image attribution tooltip
    Permission granted by Roy Mendiola

    FDA grappling with influx of illegal COVID-19 tests entering US

    The agency has issued a flurry of recent warnings about diagnostics that have been illegally imported into the country as the demand for at-home coronavirus testing increased with the omicron surge.

    By March 18, 2022
  • Image attribution tooltip
    Getty Images

    What's holding up hospital at home?

    Widespread adoption of acute-level care at home models has been hampered by physician reluctance and patchwork reimbursement, though a CMS waiver caused hospital participation to snowball during the pandemic.

    By Rebecca Pifer • March 18, 2022
  • Image attribution tooltip
    Alex Wong via Getty Images

    As White House warns of 'squandering' gains, AdvaMed sets out plan to sustain COVID-19 test capacity

    The medtech lobby is calling for the creation of a permanent public-private diagnostic testing forum and warm-base manufacturing agreements to maintain testing capacity in the event of future surges. 

    By March 17, 2022
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images
    Deep Dive

    Threats, obscenities, homicide: Healthcare workers stressed by pandemic face elevated violence

    Millions of healthcare workers across the country are becoming inured to workplace violence, which can range from verbal abuse and threats to physical attacks and even homicide.

    By Hailey Mensik • March 9, 2022
  • Image attribution tooltip
    Valeriy_G via Getty Images

    Telehealth use increased amid omicron as 2021 drew to a close

    Telehealth swelled from 4.4% of all medical claims in November to 4.9% in December, with the bump evident across the U.S., according to new Fair Health data.

    By Rebecca Pifer • March 7, 2022
  • Image attribution tooltip
    Megan Quinn/MedTech Dive

    Panel warns against 'knee-jerk' rejection of globalization, calls for medical supply chain transparency

    Instead of onshoring device manufacturing to stabilize supply chains, a congressionally-mandated committee has recommended more transparency, including disclosing manufacturing sites for all products and components.  

    By March 7, 2022
  • Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.

    Celltrion recalls 1.2M rapid COVID-19 tests for improper labeling

    The company initiated the fourth recall of its rapid COVID-19 tests in recent weeks, which the FDA designated as a Class II recall.

    By Updated March 9, 2022
  • Image attribution tooltip
    Justin Sullivan via Getty Images

    Yet another survey shows pandemic's persisting toll on healthcare workforce

    Over half of the healthcare workers recently surveyed by USA Today and Ipsos Research said they are burned out, and 39% agree with the statement: "The American healthcare system is on the verge of collapse."

    By Hailey Mensik • Feb. 23, 2022
  • Diabetes tech leaders expect another year of growth, innovation as competition soars

    MedTech Dive spoke with diabetes technology leaders about what to expect in 2022, the impact of new products and the increasingly competitive market.

    By Updated May 12, 2022
  • Image attribution tooltip
    atiatiati via Getty Images

    Smith & Nephew hires CEO from Siemens Healthineers, forecasts growth for 2022

    The orthopaedics company's stock jumped 8% on the CEO news, even though its fourth-quarter revenue fell slightly short of the analyst consensus. Smith & Nephew is more optimistic about 2022 than rivals Stryker and Zimmer Biomet.

    By Feb. 23, 2022
  • Medtronic's Q3 revenue misses estimates as omicron curbs procedures

    CEO Geoff Martha on Tuesday told investors the COVID-19 resurgence, which peaked in the final weeks of January, curbed procedure volumes. He expects them to recover in March and April.

    By Feb. 22, 2022
  • Image attribution tooltip
    Permission granted by Quidel Corporation

    Quidel expects COVID-19 test demand to continue through Q2, but offers no 2022 guidance

    CEO Doug Bryant told investors Thursday that Quidel is seeing testing demand moderate in February, but the first quarter will result in the largest revenue in the company's history. The company did not provide full-year guidance.

    By Feb. 18, 2022
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    FDA calls device manufacturing expert meeting to discuss quality system harmonization

    After the agency began transitioning its Quality System Regulation in 2018, the public may finally get to see the proposed rule in late February or early March.

    By Feb. 18, 2022
  • Image attribution tooltip
    Permission granted by Medtronic

    Medtronic talks diabetes group's FDA warning letter, new products, supply chain constraints

    Ali Dianaty, VP of product innovation and operations for Medtronic Diabetes, spoke to MedTech Dive about the warning letter's impact on product reviews, creating insulin pump patches and navigating the pandemic.

    By Feb. 18, 2022
  • Image attribution tooltip
    Sascha Schuermann via Getty Images

    Baxter begins integrating Hillrom, faces supply chain pressures

    The recent omicron surge put a damper on the company's margins, as shipping costs and healthcare staff shortages rose. Baxter expects these problems to abate in the short term and sees a long-term boost from the Hillrom acquisition.

    By Feb. 17, 2022
  • Image attribution tooltip
    Delmaine Donson via Getty Images

    Diagnostics M&A expected to be strong in 2022 after dealmaking took off last year

    Respondents to KPMG's survey predict that deal volumes and values for the diagnostics space will jump again this year as companies are ready to spend more of their COVID-19 cash.

    By Feb. 16, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images

    Inflationary risk 'manageable' for medtechs, but impact will vary: RBC

    Companies like Stryker and Zimmer Biomet, with portfolios dominated by more "commoditized" products such as traditional hip, knee and spine devices, will find it hard to pass on rising costs to customers.

    By Feb. 15, 2022
  • Hospital leaders, Congress mull fixes to current staffing woes

    The omicron variant is posing new challenges as staff call in sick or quit their jobs entirely for higher-paying traveling nurse positions. That's leaving hospitals in a bind as they treat higher acuity COVID-19 patients.

    By Hailey Mensik • Feb. 11, 2022
  • Image attribution tooltip
    Courtesy of Quest Diagnostics

    Labcorp, Quest warn COVID-19 testing demand will plummet in 2022

    The rival lab giants told investors during their latest earnings calls that they expect coronavirus-related test volumes to nose-dive by as much as 75%.

    By Feb. 11, 2022
  • Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit

    Dexcom's G7 gains CE mark after 2021 delay

    The company’s newest continuous glucose monitoring system was expected to launch in Europe in 2021, but regulatory delays pushed the release back.

    By Updated March 14, 2022
  • Image attribution tooltip
    Permission granted by Johnson & Johnson

    J&J's DePuy Synthes buys ortho company CrossRoads Extremity Systems

    The deal, for an undisclosed amount, comes just weeks after Johnson & Johnson executives said the company will have a more aggressive M&A strategy going forward for the pharmaceutical and medical devices businesses.

    By Feb. 10, 2022
  • Image attribution tooltip
    JohnnyGreig via Getty Images

    Healthcare staffing shortages a 'rising concern' for medtechs: Moody's

    In a recent quarterly report, Moody's Investors Service called out hospital labor shortages as having a potential material impact on procedures in 2022, even as the omicron surge begins to decline.

    By Feb. 9, 2022